THERAPY-RELATED ACUTE MYELOID-LEUKEMIA WITH T(8-16)(P11-P13) FOLLOWING ANTHRACYCLINE-BASED THERAPY FOR NONMETASTATIC OSTEOSARCOMA

被引：8
|
作者：
DEMUYNCK, H
VERHOEF, GEG
ZACHEE, P
VANDENBERGHE, P
VANORSHOVEN, A
PARIDAENS, R
SAMSON, I
BOOGAERTS, MA
机构：
[1] UNIV HOSP GASTHUISBERG,DEPT HEMATOL,B-3000 LOUVAIN,BELGIUM
[2] UNIV HOSP GASTHUISBERG,DEPT MED ONCOL & RADIOTHERAPY,B-3000 LOUVAIN,BELGIUM
[3] UNIV HOSP GASTHUISBERG,DEPT ORTHOPED SURG,B-3000 LOUVAIN,BELGIUM
来源：
CANCER GENETICS AND CYTOGENETICS | 1995年 / 82卷 / 02期
关键词：
D O I：
10.1016/0165-4608(95)00045-Q
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A case of therapy-related AML with t(8;16)(p11;p13) 14 months following the end of anthracycline-containing chemotherapy for a nonmetastatic osteosarcoma of the left tibia is presented. The patient was successfully treated with intensive remission-induction chemotherapy. Subsequently, he underwent an uncomplicated allogeneic bone marrow transplantation from his HLA-identical brother and is at present alive and disease-free 10 months after diagnosis of the secondary AML.
引用
收藏
页码：103 / 105
页数：3
相关论文
共 50 条
  • [31] THERAPY-RELATED ACUTE-LEUKEMIA ASSOCIATED WITH T(11Q23) AFTER PRIMARY ACUTE MYELOID-LEUKEMIA WITH T(8-21) - A REPORT OF 2 CASES
    ROULSTON, D
    ANASTASI, J
    RUDINSKY, R
    NUCIFORA, G
    ZELEZNIKLE, N
    ROWLEY, JD
    MCGAVRAN, L
    TSUCHIDA, M
    HAYASHI, Y
    BLOOD, 1995, 86 (09) : 3613 - 3614
  • [32] Therapy-related Acute Myeloid Leukemia, Characterized by t(8;16)(p11;p13);MYST3-CREBBP and Co-occurring TET2 and ASXL1 Mutations
    Alsuwaidan, A.
    Koduru, P.
    Fuda, F.
    Vusirikala, M.
    Sadeghi, N.
    Zhang, C.
    Chen, W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 926 - 927
  • [33] MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia
    Sugita, K
    Taki, T
    Hayashi, Y
    Shimaoka, H
    Kumazaki, H
    Inoue, H
    Konno, Y
    Taniwaki, M
    Kurosawa, H
    Eguchi, M
    GENES CHROMOSOMES & CANCER, 2000, 27 (03): : 264 - 269
  • [34] Translocation t(7;11)(p15;p15) in a patient with therapy-related acute myeloid leukemia following bimolane and ICRF-154 treatment for psoriasis
    Xue, YQ
    Guo, Y
    Xie, X
    LEUKEMIA RESEARCH, 1997, 21 (02) : 107 - 109
  • [35] Therapy-related Myeloid Leukemia With the Translocation t(8;19)(p11;q13) Leading to a KAT6A-LEUTX Fusion Gene
    Panagopoulos, Ioannis
    Andersen, Kristin
    Ramslien, Lloyd Frode
    Ikonomou, Ida Munster
    Micci, Francesca
    Heim, Sverre
    ANTICANCER RESEARCH, 2021, 41 (04) : 1753 - 1760
  • [36] DISTINCTIVE FLOW CYTOMETRIC AND MUTATIONAL PROFILE OF ACUTE MYELOID LEUKEMIA WITH T(8;16)(P11;P13)
    Stalling, Melissa
    Gao, Juehua
    Duncavage, Eric
    Lu, Xinyan
    Wolniak, Kristy
    Kreisel, Friederike
    Yaseen, Nabeel
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 : 140 - 140
  • [37] A DISTINCT SUBTYPE OF M4/M5 ACUTE MYELOBLASTIC-LEUKEMIA (AML) ASSOCIATED WITH T(8-16)(P11-P13), IN A PATIENT WITH THE VARIANT T(8-19)(P11-Q13) - CASE-REPORT AND REVIEW OF THE LITERATURE
    STARK, B
    RESNITZKY, P
    JEISON, M
    LURIA, D
    BLAU, O
    AVIGAD, S
    SHAFT, D
    KODMAN, Y
    GOBUZOV, R
    ASH, S
    STEIN, J
    YANIV, I
    BARAK, Y
    ZAIZOV, R
    LEUKEMIA RESEARCH, 1995, 19 (06) : 367 - 379
  • [38] Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma
    Bielorai, Bella
    Meyer, Claus
    Trakhtenbrot, Luba
    Golan, Hana
    Rozner, Esther
    Amariglio, Ninette
    Izraeli, Shai
    Marschalek, Rolf
    Toren, Amos
    CANCER GENETICS AND CYTOGENETICS, 2010, 203 (02) : 288 - 291
  • [39] FISH for the MYST3/CREBBP Fusion Associated with the t(8;16)(p11.2;p13.3) Seen in de novo and Therapy-Related Acute Myeloid Leukemia
    Knudson, R. A.
    Keefe, J. G.
    Cousin, M. A.
    Sakai, Y.
    Ketterling, R. P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 631 - 631
  • [40] Monitoring KAT6A-CREBBP measurable residual disease in t(8;16) therapy-related acute myeloid leukemia
    Bhreathnach, Una
    Doherty, Dearbhla
    Murphy, Karen
    Flynn, Catherine M.
    Langabeer, Stephen E.
    LEUKEMIA RESEARCH, 2022, 116
12345